F4A-39117-70772 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-15
Dose 1 — Pfizer-BioNTech
2021-05-07
Dose 2 — Pfizer-BioNTech
2022-01-03
Registered in v-safe
2022-01-03
Dose 3 — Pfizer-BioNTech
2022-01-04
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school

Adult check-in
2022-01-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-01-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-09
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-10
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-18
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-24
Survey response — day 21, dose 3
MedDRA: Exposure to SARS-CoV-2, Influenza like illness — Feeling: Fair · Be unable to do your normal daily activities

Free text: Flu-like subornos started yesterday. My 2- year-old tested positive for COVID two days ago.

MedDRA releases: 2024-11 · check-in free text available
2022-01-31
Survey response — day 28, dose 3
MedDRA: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school

Free text: Fatigue, sore throat, runny nose, headache

MedDRA releases: 2024-11 · check-in free text available
2022-02-07
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-14
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-06
Survey response — 3 months, dose 3
MedDRA: Fatigue — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Increased fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-07-04
Survey response — 6 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Cold-like symptoms

MedDRA releases: 2024-11 · check-in free text available
2022-07-04
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-07-05
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-03
Survey response — 12 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-03
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-04
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-15	Pfizer-BioNTech	No
2	2021-05-07	Pfizer-BioNTech	No
3	2022-01-03	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 11 — day 21, dose 3

2022-01-24

Symptoms: Flu-like subornos started yesterday. My 2- year-old tested positive for COVID two days ago.

Release 11 — day 28, dose 3

2022-01-31

Symptoms: Fatigue, sore throat, runny nose, headache

Release 11 — 3 months, dose 3

2022-04-06

Symptoms: Increased fatigue

Release 12 — 6 months, dose 3

2022-07-04

Symptoms: Cold-like symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Exposure to SARS-CoV-2	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Influenza like illness	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release